Whether you are looking for CBD for general wellness or for specific medical conditions it’s important to look for these forms of lab test results; heavy metal testing, clinical trial information (if available), pesticide testing, microbial testing, potency testing, and cannabinoid profile. While having this information provided by a CBD company is important, it doesn’t necessarily mean their product will work for you. However you do not want to consider a CBD company that doesn’t provide the testing info mentioned above. Learn more about recommended best practices to look for here.
CBD oil products needn’t be expensive, as Canabidol proves. The company’s pure cannabis oil drops, for example, sell from $28 for 10 ml, making them an affordable choice for new users still unsure about what CBD could do for them. That’s not to say that Canabidol’s goods aren’t up to scratch, though, as the business aims to ensure their quality through both its own bespoke method of analysis and by sending its oil to third-party labs. Among the products on offer, meanwhile, are innovative CBD Gel-Tabs, which feature a specially developed slow-release system designed to improve the body’s absorption of the active ingredient. And this, Canabidol claims, is “now the best-selling CBD cannabis oil product in the U.K.”
Green Gorilla marks itself out by simply blending its flagship line of CBD oils with organically produced extra virgin olive oil – and nothing else. And, as the company states, there’s a benefit to this beyond assuring the product’s purity. In particular, olive oil “has synergistic effects in combination with CBD,” and according to Green Gorilla’s website, it’s “also able to deliver the CBD to the parts of [the] body that need it most.” The products are certainly affordable, too: its 150 mg pure CBD oil comes in at $25.99, for instance, making it a smart choice for new users. And anyone still uncertain about the potential effects of Green Gorilla’s products may have their questions answered by the convenient “science” section of the manufacturer’s website, which neatly explains the difference between THC – the cannabinoid that makes people “high” – and CBD.
In response to the FDA’s historic decision, the Drug Enforcement Administration (DEA) announced in September 2018 that it had removed Epidiolex from Schedule I classification, a category reserved for dangerous drugs with no medical value. Henceforth, Epidiolex would be considered a Schedule V drug, the least dangerous designation under the Controlled Substances Act.
Transdermal Patches – Remember those patches people put on their bodies to quit smoking? These patches allowed for a slow release of nicotine over the course of a day? Well, the same idea exists with CBD patches. This is a convenient way to get CBD into your body and endocannabinoid system over the course of a day. CLICK HERE to see our favorite patch.